Alternative strategies in arrhythmia therapy: Evaluation of Na/Ca exchange as an anti-arrhythmic target

Pharmacology and Therapeutics

Volumn 134, Issue 1, 2012, Pages 26-42

  Antoons, Gudrun ^a   Willems, Rik ^a   Sipido, Karin R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Atrial fibrillation; Heart failure; Na Ca exchange; Pharmacology; Ryanodine receptor; Ventricular arrhythmias

Indexed keywords

(4,5) 3', 4' DICHLOROBENZAMIL; 2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; 2 [4 (2,5 DIFLUOROBENZYLOXY)PHENOXY] 5 ETHOXYANILINE; AMILORIDE; AMILORIDE DERIVATIVE; BEPRIDIL; CALCIUM ION; SODIUM; UNCLASSIFIED DRUG;

DRUG TARGETING; ELECTRIC ACTIVITY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HUMAN; ISCHEMIA; ISCHEMIA REPERFUSION; LONG QT SYNDROME; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SODIUM CALCIUM EXCHANGE;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; HUMANS; SODIUM-CALCIUM EXCHANGER;

EID: 84857361307     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.12.001     Document Type: Review

References (188)

1. 2+ exchange currents J Physiol 589 2011 2569 2583
2. T. Aiba, W. Shimizu, M. Inagaki, T. Noda, S. Miyoshi, W.G. Ding, D.P. Zankov, F. Toyoda, H. Matsuura, M. Horie, and K. Sunagawa Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil J Am Coll Cardiol 45 2005 300 307
3. F.G. Akar, and D.S. Rosenbaum Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure Circ Res 93 2003 638 645
4. M. Allessie, J. Ausma, and U. Schotten Electrical, contractile and structural remodeling during atrial fibrillation Cardiovasc Res 54 2002 230 246
5. M.S. Amran, K. Hashimoto, and N. Homma Effects of sodium-calcium exchange inhibitors, KB-R7943 and SEA0400, on aconitine-induced arrhythmias in guinea pigs in vivo, in vitro, and in computer simulation studies J Pharmacol Exp Ther 310 2004 83 89
6. M.E. Anderson Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias Pharmacol Ther 106 2005 39 55
7. M.E. Anderson, J.H. Brown, and D.M. Bers CaMKII in myocardial hypertrophy and heart failure J Mol Cell Cardiol 51 2011 468 473
8. W. Anne, R. Willems, P. Holemans, F. Beckers, T. Roskams, I. Lenaerts, H. Ector, and H. Heidbuchel Self-terminating AF depends on electrical remodeling while persistent AF depends on additional structural changes in a rapid atrially paced sheep model J Mol Cell Cardiol 43 2007 148 158
9. G. Antoons, A. Oros, V. Bito, K.R. Sipido, and M.A. Vos Cellular basis for triggered ventricular arrhythmias that occur in the setting of compensated hypertrophy and heart failure: considerations for diagnosis and treatment J Electrocardiol 40 2007 S8 S14
10. G. Antoons, and K.R. Sipido Targeting calcium handling in arrhythmias Europace 10 2008 1364 1369
11. 2+ exchange" by Xuan-Ping Zhang et al. Cardiovasc Drugs Ther 23 2009 189 192
12. C. Antzelevitch Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes Europace 9 Suppl 4 2007 iv4 iv15
13. A.A. Armoundas, R. Wu, G. Juang, E. Marban, and G.F. Tomaselli Electrical and structural remodeling of the failing ventricle Pharmacol Ther 92 2001 213 230
14. A. Baartscheer, C.A. Schumacher, C.N. Belterman, R. Coronel, and J.W. Fiolet SR calcium handling and calcium after-transients in a rabbit model of heart failure Cardiovasc Res 58 2003 99 108
15. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau, M. Domanski, C. Troutman, J. Anderson, G. Johnson, S.E. McNulty, N. Clapp-Channing, L.D. Davidson-Ray, E.S. Fraulo, D.P. Fishbein, R.M. Luceri, and J.H. Ip Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
16. 2+ exchange to action potential of human atrial myocytes Am J Physiol 271 1996 H1151 H1161
17. O. Berenfeld, A.V. Zaitsev, S.F. Mironov, A.M. Pertsov, and J. Jalife Frequency-dependent breakdown of wave propagation into fibrillatory conduction across the pectinate muscle network in the isolated sheep right atrium Circ Res 90 2002 1173 1180
18. + regulation in cardiac myocytes Cardiovasc Res 57 2003 897 912
19. D.M. Bers, and K.S. Ginsburg Na:Ca stoichiometry and cytosolic Ca-dependent activation of NCX in intact cardiomyocytes Ann N Y Acad Sci 1099 2007 326 338
20. D.M. Bers, and E. Grandi Calcium/calmodulin-dependent kinase II regulation of cardiac ion channels J Cardiovasc Pharmacol 54 2009 180 187
21. L. Biesmans, N. Macquaide, F.R. Heinzel, V. Bito, G.L. Smith, and K.R. Sipido Subcellular heterogeneity of ryanodine receptor properties in ventricular myocytes with low T-tubule density 2011
22. G.E. Billman Vernakalant, a mixed sodium and potassium ion channel antagonist that blocks K(v)1.5 channels, for the potential treatment of atrial fibrillation Curr Opin Investig Drugs 11 2010 1048 1058
23. M.P. Blaustein, and W.J. Lederer Sodium/calcium exchange: its physiological implications Physiol Rev 79 1999 763 854
24. E. Carmeliet Cardiac ionic currents and acute ischemia: from channels to arrhythmias Physiol Rev 79 1999 917 1017
25. M. Cerrone, S.F. Noujaim, E.G. Tolkacheva, A. Talkachou, R. O'Connell, O. Berenfeld, J. Anumonwo, S.V. Pandit, K. Vikstrom, C. Napolitano, S.G. Priori, and J. Jalife Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia Circ Res 101 2007 1039 1048
26. Y.J. Chen, S.A. Chen, Y.C. Chen, H.I. Yeh, P. Chan, M.S. Chang, and C.I. Lin Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation Circulation 104 2001 2849 2854
27. Y.J. Chen, Y.C. Chen, H.I. Yeh, C.I. Lin, and S.A. Chen Electrophysiology and arrhythmogenic activity of single cardiomyocytes from canine superior vena cava Circulation 105 2002 2679 2685
28. S.A. Chen, Y.J. Chen, H.I. Yeh, C.T. Tai, Y.C. Chen, and C.I. Lin Pathophysiology of the pulmonary vein as an atrial fibrillation initiator Pacing Clin Electrophysiol 26 2003 1576 1582
29. T. Chin, K.W. Spitzer, K.D. Philipson, and J.H.B. Bridge The effect of exchanger inhibitory peptide (XIP) on sodium-calcium exchange current in guinea pig ventricular cells Circ Res 72 1993 497 503
30. 2+ and trigger ventricular arrhythmias in mice Circ Res 101 2007 617 626
31. F.J. Chorro, I. Trapero, L. Such-Miquel, F. Pelechano, L. Mainar, J. Canoves, A. Tormos, A. Alberola, L. Hove-Madsen, J. Cinca, and L. Such Pharmacological modifications of the stretch-induced effects on ventricular fibrillation in perfused rabbit hearts Am J Physiol Heart Circ Physiol 297 2009 H1860 H1869
32. C.E. Clancy, and Y. Rudy Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia Nature 400 1999 566 569
33. M. Condrescu, and J.P. Reeves Inhibition of sodium-calcium exchange by KB-R7943: dodecylamine and sphingosine in transfected Chinese hamster ovary cells Cell Calcium 47 2010 404 411
34. S. Currie, E.B. Elliott, G.L. Smith, and C.M. Loughrey Two candidates at the heart of dysfunction: the ryanodine receptor and calcium/calmodulin protein kinase II as potential targets for therapeutic intervention-an in vivo perspective Pharmacol Ther 131 2011 204 220
35. K. Davia, E. Bernobich, H.K. Ranu, F. del Monte, C.M. Terracciano, K.T. MacLeod, D.L. Adamson, B. Chaudhri, R.J. Hajjar, and S.E. Harding SERCA2A overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes J Mol Cell Cardiol JID 0262322 33 2001 1005 1015
36. F. del Monte, S.E. Harding, G.W. Dec, J.K. Gwathmey, and R.J. Hajjar Targeting phospholamban by gene transfer in human heart failure Circulation 105 2002 904 907
37. F. del Monte, D. Lebeche, J.L. Guerrero, T. Tsuji, A.A. Doye, J.K. Gwathmey, and R.J. Hajjar Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling Proc Natl Acad Sci U S A 101 2004 5622 5627
38. S. Despa, F. Brette, C.H. Orchard, and D.M. Bers Na/Ca exchange and Na/K-ATPase function are equally concentrated in transverse tubules of rat ventricular myocytes Biophys J 85 2003 3388 3396
39. M.R. di Barletta, S. Viatchenko-Karpinski, A. Nori, M. Memmi, D. Terentyev, F. Turcato, G. Valle, N. Rizzi, C. Napolitano, S. Gyorke, P. Volpe, and S.G. Priori Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia Circulation 114 2006 1012 1019
40. 2+ transient of failing human ventricular myocytes Circ Res 84 1999 435 444
41. J. Eckstein, S. Verheule, N. de Groot, M. Allessie, and U. Schotten Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria Prog Biophys Mol Biol 97 2008 435 451
42. J.R. Ehrlich, T.J. Cha, L. Zhang, D. Chartier, P. Melnyk, S.H. Hohnloser, and S. Nattel Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties J Physiol (Lond) 551 2003 801 813
43. D.A. Eisner, T. Kashimura, S.C. O'Neill, L.A. Venetucci, and A.W. Trafford What role does modulation of the ryanodine receptor play in cardiac inotropy and arrhythmogenesis? J Mol Cell Cardiol 46 2009 474 481
44. 2+ handling in human chronic atrial fibrillation Circulation 114 2006 670 680
45. 2+ exchange by KB-R7943: transport mode selectivity and antiarrhythmic consequences Am J Physiol Heart Circ Physiol 281 2001 H1334 H1345
46. A.E. Epstein An update on implantable cardioverter-defibrillator guidelines Curr Opin Cardiol 19 2004 23 25
47. i overloaded myocytes: a simulation study Biophys J 78 2000 2392 2404
48. 2+ exchanger, I(Na) and I(CaL) in the genesis of dofetilide-induced torsades de pointes in isolated, AV-blocked rabbit hearts Br J Pharmacol 156 2009 920 932
49. 2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury J Cardiovasc Pharmacol 47 2006 263 270
50. G.R. Ferrier, C.M. Guyette, and G.R. Li Cellular mechanisms of reperfusion arrhythmias: studies in isolated ventricular tissue preparations D.P. Zipes, J. Jalife, Cardiac Electrophysiology: From Cell to Bedside 1990 W.B.Saunders New York 433 441
51. G.R. Ferrier, J.H. Saunders, and C. Mendez A cellular mechanism for the generation of ventricular arrhythmias by acetylstrophanthidin Circ Res 32 1973 600 609
52. 2+ exchanger, NCX1 and NCX3, constitute novel additional targets for the prosurvival action of Akt/protein kinase B pathway Mol Pharmacol 73 2008 727 737
53. 2+ in the heart Circ Res 103 2008 509 518
54. K. Gjesdal Non-investigational antiarrhythmic drugs: long-term use and limitations Expert Opin Drug Saf 8 2009 345 355
55. A. Goette, C. Honeycutt, and J.J. Langberg Electrical remodeling in atrial fibrillation. Time course and mechanisms Circulation 94 1996 2968 2974
56. 2+ exchange during cardiac hypertrophy after myocardial infarction Circ Res 91 2002 323 330
57. M. Haissaguerre, P. Jais, D.C. Shah, A. Takahashi, M. Hocini, G. Quiniou, S. Garrigue, A. Le Mouroux, P. Le Metayer, and J. Clementy Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins N Engl J Med 339 1998 659 666
58. G. Hasenfuss, and B. Pieske Calcium cycling in congestive heart failure J Mol Cell Cardiol 34 2002 951 969
59. 2+-exchanger protein levels and diastolic function of failing human myocardium Circulation 99 1999 641 648
60. 2+ release in myocytes from chronically ischemic myocardium Circ Res 102 2008 338 346
61. 2+ exchanger Am J Physiol Cell Physiol 287 2004 C1167 C1172
62. D.W. Hilgemann, A. Yaradanakul, Y. Wang, and D. Fuster Molecular control of cardiac sodium homeostasis in health and disease J Cardiovasc Electrophysiol 17 2006 S47 S56
63. I.A. Hobai, C. Maack, and B. O'Rourke Partial Inhibition of sodium/calcium exchange restores cellular calcium handling in canine heart failure Circ Res 95 2004 292 299
64. R.B. Huffaker, R. Samade, J.N. Weiss, and B. Kogan Tachycardia-induced early afterdepolarizations: insights into potential ionic mechanisms from computer simulations Comput Biol Med 38 2008 1140 1151
65. M. Ibrahim, A. Al Masri, M. Navaratnarajah, U. Siedlecka, G.K. Soppa, A. Moshkov, S.A. Al Saud, J. Gorelik, M.H. Yacoub, and C.M. Terracciano Prolonged mechanical unloading affects cardiomyocyte excitation-contraction coupling, transverse-tubule structure, and the cell surface FASEB J 24 2010 3321 3329
66. 2+ exchanger confers protection against ischemia/reperfusion injury Circ Res 97 2005 916 921
67. 2+ exchange by SN-6 [2-[4-(4-nitrobenzyloxy)benzyl] thiazolidine-4-carboxylic acid ethyl ester], a novel benzyloxyphenyl derivative Mol Pharmacol 66 2004 45 55
68. 2+ exchange (NCX1) inhibition by SEA0400 J Biol Chem 279 2004 7544 7553
69. 2+ exchanger type-1 in vascular smooth muscle Nat Med 10 2004 1193 1199
70. 2+ exchange in cells expressing NCX1 J Biol Chem 271 1996 22391 22397
71. M.J. Janse Electrophysiological changes in heart failure and their relationship to arrhythmogenesis Cardiovasc Res 61 2004 208 217
72. D.M. Johnson, J. Heijman, C.E. Pollard, J.P. Valentin, H.J. Crijns, N. Abi-Gerges, and P.G. Volders I(Ks) restricts excessive beat-to-beat variability of repolarization during beta-adrenergic receptor stimulation J Mol Cell Cardiol 48 2010 122 130
73. 2+ exchanger as a new therapeutic target for heart failure with preserved ejection fraction Eur Heart J 2011 (First published online: April 13, 2011). doi:10.1093/eurheartj/ehr106.
74. 2+ exchanger Nature 427 2004 544 548
75. M.J. Kendall Clinical trial data on the cardioprotective effects of beta-blockade Basic Res Cardiol 95 Suppl 1 2000 I25 I30
76. 2+ entry, ryanodine function, and kinase inhibitors on a rabbit model of heart failure Int Heart J 51 2010 285 290
77. 2+ exchange current by KB-R7943 in guinea-pig cardiac myocytes Br J Pharmacol 128 1999 969 974
78. B.C. Knollmann Power and pitfalls of using transgenic mice to optimize therapy for CPVT: a need for prospective placebo-controlled clinical trials in genetic arrhythmia disorders Heart Rhythm 7 2010 1683 1685
79. K. Kumagai, H. Nakashima, N. Gondo, and K. Saku Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model J Cardiovasc Electrophysiol 14 2003 880 884
80. 2+ exchanger Am J Physiol 276 1999 H1868 H1876
81. H. Lahat, E. Pras, T. Olender, N. Avidan, E. Ben Asher, O. Man, E. Levy-Nissenbaum, A. Khoury, A. Lorber, B. Goldman, D. Lancet, and M. Eldar A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel Am J Hum Genet 69 2001 1378 1384
82. P.J. Laitinen, K.M. Brown, K. Piippo, H. Swan, J.M. Devaney, B. Brahmbhatt, E.A. Donarum, M. Marino, N. Tiso, M. Viitasalo, L. Toivonen, D.A. Stephan, and K. Kontula Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia Circulation 103 2001 485 490
83. N. Leblanc, and J.R. Hume Sodium current-induced release of calcium from cardiac sarcoplasmic reticulum Science 248 1990 372 376
84. W.J. Lederer, E. Niggli, and R.W. Hadley Sodium-calcium exchange in excitable cells: fuzzy space Science 248 1990 283
85. 2+ exchanger, NCX1.1 J Pharmacol Exp Ther 311 2004 748 757
86. 2+ exchanger, NCX1.1 J Pharmacol Exp Ther 311 2004 748 757
87. S.E. Lehnart, M.J. Ackerman, D.W. Benson Jr., R. Brugada, C.E. Clancy, J.K. Donahue, A.L. George Jr., A.O. Grant, S.C. Groft, C.T. January, D.A. Lathrop, W.J. Lederer, J.C. Makielski, P.J. Mohler, A. Moss, J.M. Nerbonne, T.M. Olson, D.A. Przywara, J.A. Towbin, L.H. Wang, and A.R. Marks Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function Circulation 116 2007 2325 2345
88. S.E. Lehnart, and W.J. Lederer An antidote for calcium leak: targeting molecular arrhythmia mechanisms J Mol Cell Cardiol 48 2010 279 282
89. S.E. Lehnart, C. Terrenoire, S. Reiken, X.H. Wehrens, L.S. Song, E.J. Tillman, S. Mancarella, J. Coromilas, W.J. Lederer, R.S. Kass, and A.R. Marks Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias Proc Natl Acad Sci U S A 103 2006 7906 7910
90. 2+ release in right atrial myocytes from experimental persistent atrial fibrillation Circ Res 105 2009 876 885
91. C. Lenfant Shattuck lecture - clinical research to clinical practice - lost in translation? N Engl J Med 349 2003 868 874
92. N. Liu, M. Denegri, Y. Ruan, J.E. Avelino-Cruz, A. Perissi, S. Negri, C. Napolitano, W.A. Coetzee, P.A. Boyden, and S.G. Priori Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity Circ Res 109 2011 291 295
93. 2+ release in normal adult rabbit ventricular cardiomyocytes Cardiovasc Res 76 2007 236 246
94. 2+ influx Eur J Pharmacol 365 1999 233 239
95. C.H. Luo, and Y. Rudy A dynamic model of the cardiac ventricular action potential. I. Simulations of ionic currents and concentration changes Circ Res 74 1994 1071 1096
96. A.R. Lyon, K.T. MacLeod, Y. Zhang, E. Garcia, G.K. Kanda, M.J. Lab, Y.E. Korchev, S.E. Harding, and J. Gorelik Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart Proc Natl Acad Sci U S A 106 2009 6854 6859
97. A.C. MacDonald, and S.E. Howlett Differential effects of the sodium calcium exchange inhibitor, KB-R7943, on ischemia and reperfusion injury in isolated guinea pig ventricular myocytes Eur J Pharmacol 580 2008 214 223
98. 2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes J Physiol 587 2009 3113 3115
99. S.O. Marx, S. Reiken, Y. Hisamatsu, T. Jayaraman, D. Burkhoff, N. Rosemblit, and A.R. Marks PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts Cell 101 2000 365 376
100. 2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models J Pharmacol Exp Ther 298 2001 249 256
101. J. McMurray, and M.A. Pfeffer New therapeutic options in congestive heart failure: part II Circulation 105 2002 2223 2228
102. 2+ exchanger suppresses torsades de pointes in an intact heart model of long QT syndrome-2 and long QT syndrome-3 Heart Rhythm 5 2008 1444 1452
103. 2+ exchange inhibitor, does not suppress ischemia/reperfusion arrhythmias nor digitalis arrhythmias in dogs Jpn J Pharmacol 90 2002 229 235
104. A. Miyata, D.P. Zipes, S. Hall, and M. Rubart Kb-R7943 prevents acute, atrial fibrillation-induced shortening of atrial refractoriness in anesthetized dogs Circulation 106 2002 1410 1419
105. P.J. Mohler, J.J. Schott, A.O. Gramolini, K.W. Dilly, S. Guatimosim, W.H. duBell, L.S. Song, K. Haurogne, F. Kyndt, M.E. Ali, T.B. Rogers, W.J. Lederer, D. Escande, H. Le Marec, and V. Bennett Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death Nature 421 2003 634 639
106. P.J. Mohler, I. Splawski, C. Napolitano, G. Bottelli, L. Sharpe, K. Timothy, S.G. Priori, M.T. Keating, and V. Bennett A cardiac arrhythmia syndrome caused by loss of ankyrin-B function Proc Natl Acad Sci U S A 101 2004 9137 9142
107. 2+ exchanger 3 (NCX3) gene leads to a worsening of ischemic brain damage J Neurosci 28 2008 1179 1184
108. N. Morita, J.H. Lee, A. Bapat, M.C. Fishbein, W.J. Mandel, P.S. Chen, J.N. Weiss, and H.S. Karagueuzian Glycolytic inhibition causes spontaneous ventricular fibrillation in aged hearts Am J Physiol Heart Circ Physiol 301 2011 H180 H191
109. 2+ exchange, KB-R7943, on reoxygenation-induced injuries in guinea pig papillary muscles J Cardiovasc Pharmacol 35 2000 121 128
110. 2+ exchange inhibitor, on ventricular arrhythmias in the in vivo dogs Eur J Pharmacol 506 2005 249 255
111. Z.A. Nagy, L. Virag, A. Toth, P. Biliczki, K. Acsai, T. Banyasz, P. Nanasi, J.G. Papp, and A. Varro Selective inhibition of sodium-calcium exchanger by SEA-0400 decreases early and delayed afterdepolarization in canine heart Br J Pharmacol 143 2004 827 831
112. H. Nakaya, Y. Furusawa, T. Ogura, M. Tamagawa, and H. Uemura Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts Br J Pharmacol 131 2000 1363 1372
113. 2+ exchanger in the automaticity of guinea-pig pulmonary vein myocardium as revealed by SEA0400 J Pharmacol Sci 110 2009 111 116
114. P. Neco, B. Rose, N. Huynh, R. Zhang, J.H. Bridge, K.D. Philipson, and J.I. Goldhaber Sodium-calcium exchange is essential for effective triggering of calcium release in mouse heart Biophys J 99 2010 755 764
115. J. Nemec, J.J. Kim, B. Gabris, and G. Salama Calcium oscillations and T-wave lability precede ventricular arrhythmias in acquired long QT type 2 Heart Rhythm 7 2010 1686 1694
116. D.A. Nicoll, X. Ren, M. Ottolia, M. Phillips, A.R. Paredes, J. Abramson, and K.D. Philipson What we know about the structure of NCX1 and how it relates to its function Ann N Y Acad Sci 1099 2007 1 6
117. 2+ exchange inhibitor in guinea pig cardiac ventricular myocytes Eur J Pharmacol 573 2007 161 169
118. D. Noble, S.J. Noble, G.C. Bett, Y.E. Earm, W.K. Ho, and I.K. So The role of sodium-calcium exchange during the cardiac action potential Ann N Y Acad Sci 639 1991 334 353
119. D. Nuyens, M. Stengl, S. Dugarmaa, T. Rossenbacker, V. Compernolle, Y. Rudy, J.F. Smits, W. Flameng, C.E. Clancy, L. Moons, M.A. Vos, M. Dewerchin, K. Benndorf, D. Collen, E. Carmeliet, and P. Carmeliet Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome Nat Med 7 2001 1021 1027
120. 2+ exchanger knockout mouse model Biochem Biophys Res Commun 314 2004 849 853
121. 2+ from the sarcoplasmic reticulum in rat ventricular myocytes J Physiol 559 2004 121 128
122. 2+ exchanger J Biol Chem 284 2009 32735 32741
123. 2+ load attributable to the predominance of forward mode block Circ Res 102 2008 1398 1405
124. D.L. Packer, J.M. Prutkin, A.S. Hellkamp, L.B. Mitchell, R.C. Bernstein, F. Wood, J.P. Boehmer, M.D. Carlson, R.P. Frantz, S.E. McNulty, J.G. Rogers, J. Anderson, G.W. Johnson, M.N. Walsh, J.E. Poole, D.B. Mark, K.L. Lee, and G.H. Bardy Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial Circulation 120 2009 2170 2176
125. i and contractility in nonfailing and failing human myocardium Circulation 106 2002 447 453
126. H.M. Piper, D. Garcia-Dorado, and M. Ovize A fresh look at reperfusion injury Cardiovasc Res 38 1998 291 300
127. S.M. Pogwizd, K. Schlotthauer, L. Li, W. Yuan, and D.M. Bers Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual ß-adrenergic responsiveness Circ Res 88 2001 1159 1167
128. S.M. Pogwizd, K.R. Sipido, F. Verdonck, and D.M. Bers Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis Cardiovasc Res 57 2003 887 896
129. S.G. Priori, M.M. Mantica, C. Napolitano, and P.J. Schwartz Early afterdepolarizations induced in vivo by reperfusion of ischemic myocardium Circulation 81 1990 1911 1920
130. S.G. Priori, C. Napolitano, and M. Cerrone Experimental therapy of genetic arrhythmias: disease-specific pharmacology Handb Exp Pharmacol 2006 267 286
131. S.G. Priori, C. Napolitano, N. Tiso, M. Memmi, G. Vignati, R. Bloise, V. Sorrentino, and G.A. Danieli Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia Circulation 103 2001 196 200
132. X. Qi, Y.H. Yeh, D. Chartier, L. Xiao, Y. Tsuji, B.J. Brundel, I. Kodama, and S. Nattel The calcium/calmodulin/kinase system and arrhythmogenic afterdepolarizations in bradycardia-related acquired long-QT syndrome Circ Arrhythm Electrophysiol 2 2009 295 304
133. 2+ exchanger in migration and contraction of rat cultured tendon fibroblasts J Physiol 587 2009 5345 5359
134. M.C. Sanguinetti, and P.B. Bennett Antiarrhythmic drug target choices and screening Circ Res 93 2003 491 499
135. 2+ overload in rat ventricular myocytes Circulation 101 2000 1441 1446
136. 2+ exchange under normal and sodium-loaded conditions in mammalian ventricles Mol Cell Biochem 242 2003 11 17
137. 2+ exchanger in reoxygenation-induced cardiomyocyte injury Cardiovasc Res 51 2001 241 250
138. U. Schotten, M. Greiser, D. Benke, K. Buerkel, B. Ehrenteidt, C. Stellbrink, J.F. Vazquez-Jimenez, F. Schoendube, P. Hanrath, and M. Allessie Atrial fibrillation-induced atrial contractile dysfunction: a
139. U. Schotten, S. Verheule, P. Kirchhof, and A. Goette Pathophysiological mechanisms of atrial fibrillation: a translational appraisal Physiol Rev 91 2011 265 325
140. W. Shimizu, and M. Horie Phenotypic manifestations of mutations in genes encoding subunits of cardiac potassium channels Circ Res 109 2011 97 109
141. 2+ exchange by KB-R7943 augments arrhythmogenicity in the canine heart during rapid heart rates J Electrocardiol 38 2005 218 225
142. 2+ exchanger on ouabain-induced arrhythmias in the atria and ventricle strips of guinea pig Eur J Pharmacol 553 2006 196 204
143. K.R. Sipido, A. Varro, and D. Eisner Sodium calcium exchange as a target for antiarrhythmic therapy Handb Exp Pharmacol 2006 159 199
144. 2+ release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: a potential link between contractile adaptation and arrhythmogenesis Circulation 102 2000 2137 2144
145. K.R. Sipido, P.G. Volders, M.A. Vos, and F. Verdonck Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy? Cardiovasc Res 53 2002 782 805
146. L. Song, R. Alcalai, M. Arad, C.M. Wolf, O. Toka, D.A. Conner, C.I. Berul, M. Eldar, C.E. Seidman, and J.G. Seidman Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia J Clin Invest 117 2007 1814 1823
147. Y. Song, J.C. Shryock, and L. Belardinelli An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes Am J Physiol Heart Circ Physiol 294 2008 H2031 H2039
148. 2+/calmodulin-dependent protein kinase II improves contractility in human failing myocardium Circ Res 107 2010 1150 1161
149. M. Stein, M. Boulaksil, J.A. Jansen, E. Herold, M. Noorman, J.A. Joles, T.A. van Veen, M.J. Houtman, M.A. Engelen, R.N. Hauer, J.M. de Bakker, and H.V. van Rijen Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model Am J Physiol Heart Circ Physiol 299 2010 H310 H321
150. 2+ exchange current to the formation of delayed afterdepolarizations in intact rat ventricular muscle J Cardiovasc Pharmacol 53 2009 517 522
151. A. Takahara, T. Sugimoto, T. Kitamura, K. Takeda, Y. Tsuneoka, I. Namekata, and H. Tanaka Electrophysiological and pharmacological characteristics of triggered activity elicited in guinea-pig pulmonary vein myocardium J Pharmacol Sci 115 2011 176 181
152. 2+ exchanger, on myocardial ischemia-reperfusion injuries Eur J Pharmacol 458 2003 155 162
153. 2+ exchanger Naunyn Schmiedebergs Arch Pharmacol 371 2005 526 534
154. H. Tanaka, K. Nishimaru, T. Aikawa, W. Hirayama, Y. Tanaka, and K. Shigenobu Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents Br J Pharmacol 135 2002 1096 1100
155. 2+ exchanger in ouabain-induced inotropy and arrhythmogenesis in guinea-pig myocardium as revealed by SEA0400 J Pharmacol Sci 103 2007 241 246
156. M.B. Thomsen, S.C. Verduyn, M. Stengl, J.D. Beekman, G. de Pater, J. van Opstal, P.G. Volders, and M.A. Vos Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs Circulation 110 2004 2453 2459
157. K. Toischer, A.G. Rokita, B. Unsold, W. Zhu, G. Kararigas, S. Sossalla, S.P. Reuter, A. Becker, N. Teucher, T. Seidler, C. Grebe, L. Preuss, S.N. Gupta, K. Schmidt, S.E. Lehnart, M. Kruger, W.A. Linke, J. Backs, V. Regitz-Zagrosek, K. Schafer, L.J. Field, L.S. Maier, and G. Hasenfuss Differential cardiac remodeling in preload versus afterload Circulation 122 2010 993 1003
158. G.F. Tomaselli, and E. Marban Electrical remodeling in hypertrophy and heart failure Cardiovasc Res 42 1999 270 284
159. A.W. Trafford, M.E. Diaz, S.C. O'Neill, and D.A. Eisner Comparison of subsarcolemmal and bulk calcium concentration during spontaneous calcium release in rat ventricular myocytes J Physiol (Lond) 488 1995 577 586
160. C.T. Tsai, F.T. Chiang, W.P. Chen, J.J. Hwang, C.D. Tseng, C.K. Wu, C.C. Yu, Y.C. Wang, L.P. Lai, and J.L. Lin Angiotensin II induces complex fractionated electrogram in a cultured atrial myocyte monolayer mediated by calcium and sodium-calcium exchanger Cell Calcium 49 2011 1 11
161. H. Uchinoumi, M. Yano, T. Suetomi, M. Ono, X. Xu, H. Tateishi, T. Oda, S. Okuda, M. Doi, S. Kobayashi, T. Yamamoto, Y. Ikeda, T. Ohkusa, N. Ikemoto, and M. Matsuzaki Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor Circ Res 106 2010 1413 1424
162. G. Valle, D. Galla, A. Nori, S.G. Priori, S. Gyorke, F. de, V, and P. Volpe Catecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin Biochem J 413 2008 291 303
163. A. Varro, P. Biliczki, N. Iost, L. Virag, O. Hala, P. Kovacs, P. Matyus, and J.G. Papp Theoretical possibilities for the development of novel antiarrhythmic drugs Curr Med Chem 11 2004 1 11
164. M.W. Veldkamp, A.O. Verkerk, A.C. van Ginneken, A. Baartscheer, C. Schumacher, N. de Jonge, J.M. de Bakker, and T. Opthof Norepinephrine induces action potential prolongation and early afterdepolarizations in ventricular myocytes isolated from human end-stage failing hearts Eur Heart J 22 2001 955 963
165. L.A. Venetucci, A.W. Trafford, and D.A. Eisner Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves: threshold sarcoplasmic reticulum calcium content is required Circ Res 100 2007 105 111
166. L.A. Venetucci, A.W. Trafford, S.C. O'Neill, and D.A. Eisner The sarcoplasmic reticulum and arrhythmogenic calcium release Cardiovasc Res 77 2008 285 292
167. + transport mechanisms in cardiac hypertrophy and failure J Mol Cell Cardiol 35 2003 5 25
168. A.O. Verkerk, M.W. Veldkamp, A. Baartscheer, C.A. Schumacher, C. Klopping, A.C. van Ginneken, and J.H. Ravesloot Ionic mechanism of delayed afterdepolarizations in ventricular cells isolated from human end-stage failing hearts Circulation 104 2001 2728 2733
169. P.G.A. Volders, A. Kulcsar, M.A. Vos, K.R. Sipido, H.J. Wellens, R. Lazzara, and B. Szabo Similarities between early and delayed afterdepolarizations induced by isoproterenol in canine ventricular myocytes Cardiovasc Res 34 1997 348 359
170. 2+ exchange Am J Physiol Heart Circ Physiol 300 2011 H859 H868
171. 2+ exchange inhibitor, KB-R7943 on ouabain-induced arrhythmias in guinea-pigs Br J Pharmacol 127 1999 1846 1850
172. 2+ exchange current in guinea-pig cardiac ventricular cells Br J Pharmacol 119 1996 555 563
173. 2+] during the cardiac action potential Circ Res 90 2002 182 189
174. C.R. Weber, V. Piacentino III, S.R. Houser, and D.M. Bers Dynamic regulation of sodium/calcium exchange function in human heart failure Circulation 108 2003 2224 2229
175. + channel alpha-subunit: a computational analysis Circulation 102 2000 584 590
176. X.H. Wehrens, S.E. Lehnart, S.R. Reiken, S.X. Deng, J.A. Vest, D. Cervantes, J. Coromilas, D.W. Landry, and A.R. Marks Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2 Science 304 2004 292 296
177. S. Wei, A. Guo, B. Chen, W. Kutschke, Y.P. Xie, K. Zimmerman, R.M. Weiss, M.E. Anderson, H. Cheng, and L.S. Song T-tubule remodeling during transition from hypertrophy to heart failure Circ Res 107 2010 520 531
178. J.N. Weiss, A. Garfinkel, H.S. Karagueuzian, P.S. Chen, and Z. Qu Early afterdepolarizations and cardiac arrhythmias Heart Rhythm 7 2010 1891 1899
179. R.L. Winslow, J.J. Rice, S. Jafri, E. Marban, and B. O'Rourke Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies Circ Res 84 1999 571 586
180. 2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity Cardiovasc Res 70 2006 497 508
181. 2+ exchanger J Mol Cell Cardiol 33 2001 1861 1869
182. 2+ exchange inhibitor, KB-R7943, protects ischemic reperfused aged Fischer 344 rat hearts: considerable strain difference in the sensitivity to KB-R7943 Cardiovasc Res 52 2001 397 406
183. Y.C. Yang, M.J. Fann, W.H. Chang, L.H. Tai, J.H. Jiang, and L.S. Kao Regulation of sodium-calcium exchanger activity by creatine kinase under energy-compromised conditions J Biol Chem 285 2010 28275 28285
184. 2+ exchange activity is localized in the T-tubules of rat ventricular myocytes Circ Res 91 2002 315 322
185. A. Yaradanakul, T.M. Wang, V. Lariccia, M.J. Lin, C. Shen, X. Liu, and D.W. Hilgemann Massive Ca-induced membrane fusion and phospholipid changes triggered by reverse Na/Ca exchange in BHK fibroblasts J Gen Physiol 132 2008 29 50
186. L. Yue, P. Melnyk, R. Gaspo, Z. Wang, and S. Nattel Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation Circ Res 84 1999 776 784
187. 2+ exchange Cardiovasc Drugs Ther 23 2009 207 214
188. D.P. Zipes, A.J. Camm, M. Borggrefe, A.E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A.J. Moss, R.J. Myerburg, S.G. Priori, M.A. Quinones, D.M. Roden, M.J. Silka, C. Tracy, J.J. Blanc, A. Budaj, V. Dean, J.W. Deckers, C. Despres, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J.L. Tamargo, J.L. Zamorano, S.C. Smith Jr., A.K. Jacobs, C.D. Adams, E.M. Antman, J.L. Anderson, S.A. Hunt, J.L. Halperin, R. Nishimura, J.P. Ornato, R.L. Page, and B. Riegel ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Eur Heart J 27 2006 2099 2140